EPIX is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.
HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
MyStockHarbor.com
NEWS SCORE
50/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
55
Neutral based on actual EPS/revenue
Confidence
Low
Headline depth
Last Price
$0.20
Trend Context
Mixed / range
Latest briefing
What's happening with EPIX
Ad Hoc8 Jul 2026
ESSA Pharma Inc pipeline advances in prostate cancer. EPIX stock reflects a high-risk biotech profil - Ad Hoc News
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOcUxzT0RyUjJGMklEZHA1RWk3dHp2akV0WURHRkVnZkpPbzNpaXl2YzV5dHdOckVYUkVSQ3JCZWhoUlBDUWdDMGEzbENrTmN0Tk1NdzJSUGpMV2ZVSGdYLVBGQjA2cWVLUUFzdk40Yk5vZlUtTTZrM0s3ODU1d2xpM0h6VlpFb2ZzYWdzc1YyalZ0YThXV2M1dnlNQzRGRG9ldWZFdHNjLWdQMmY0eUYybE0xclBoa2lhOUJweUZXdFF5aTUwZkdSRFhsbw?oc=5" target="_blank">ESSA Pharma Inc pipeline advances in prostate cancer. EPIX stock reflects a high-risk biotech profil</a> <font color="#6f6f6f">Ad Hoc News</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Ad Hoc27 Jun 2026
Garmin Epix Pro (Gen 2) from Garmin Ltd. - bright AMOLED, multi-size choice and long GPS stamina - Ad Hoc News
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOZ2F5MTU2OWFwYnBsZ1U0RjFvNVpMd1huc3hxVUo2SDlocDY3STBLNERQd1NURTlSb09DMFZNYVhKYl93QzhIaFRxZ2k0UmI1Rld5YVB3QUQtazFMbWhpUHpQNm5LalhVbGQ3b0tEQWFpV0xsTHc4Q21jckJVT0dqZWtXZVd6NE05Vm03NnJ3WWRGTEd3TWxSb0xZUmZyS3ZPVnZybTBwQVNrNDhMTjNzel9Vb29vaWZCM3hkQ2dR?oc=5" target="_blank">Garmin Epix Pro (Gen 2) from Garmin Ltd. - bright AMOLED, multi-size choice and long GPS stamina</a> <font color="#6f6f6f">Ad Hoc News</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Kotaku22 Jun 2026
Garmin Slashes 50% Off the epix Pro (Gen 2) Sapphire Edition to Clear Out GPS Smartwatch Stock on Amazon - Kotaku
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOWEVsc2dLYTZHT001ejJSa2RsLVVxTVVMOUo1R1M3LWw1Q3oycEJnWGhTLVJfQVVCR3FTUlNXTmFSUWlzVE9abDJ0eEFxY3dOdTVwQnd0XzVRTUVWeHFYNUFoYzNWS0R2Z0RQS3FiOXM1Sm9KeTJEZ3h4a0ctdHN1X2psd0NZam8yN21ISXJud0ZlbW5kR3NmQkp2Qmw2RzV5WTVzbTZXeHdxekV0VHg2bEVjTzJMSFR3MWs5bVVWalVnWFQ5dXl6azRJUQ?oc=5" target="_blank">Garmin Slashes 50% Off the epix Pro (Gen 2) Sapphire Edition to Clear Out GPS Smartwatch Stock on Amazon</a> <font color="#6f6f6f">Kotaku</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Investing.com
9 Oct 2025
XenoTherapeutics completes acquisition of ESSA Pharma - Investing.com
